The Patent Finder

Xantech Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Xantech Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Xantech Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,201,914Combination antiperspirant and antimicrobial composition
Formerly held
Term ended
Term ended May 15, 2024 · USPTO record
Term endedTerm ended May 15, 2024USPTO record
US 7,427,389Diagnostic agents for positron emission imaging using radiolabeled halogenated xanthenes
Formerly held
Lapsed on the fee record
Ended Sep 23, 2020 · USPTO record
Lapsed on the fee recordEnded Sep 23, 2020USPTO record
US 6,451,597Method for Enhanced Protein Stabilization and for Production of Cell Lines Useful for Production of Such Stabilized Proteins
Formerly held
Term ended
Term ended Apr 6, 2020 · Medium confidence
Term endedTerm ended Apr 6, 2020Medium confidence
US 6,468,777Method for Enhanced Protein Stabilization and for Production of Cell Lines Useful for Production of Such Stabilized Proteins
Formerly held
Term ended
Term ended Apr 6, 2020 · Medium confidence
Term endedTerm ended Apr 6, 2020Medium confidence
US 6,495,360Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins
Formerly held
Term ended
Term ended Apr 6, 2020 · USPTO record
Term endedTerm ended Apr 6, 2020USPTO record
US 6,541,223Method for Enhanced Protein Stabilization and for Production of Cell Lines Useful for Production of Such Stabilized Proteins
Formerly held
Term ended
Term ended Apr 6, 2020 · Medium confidence
Term endedTerm ended Apr 6, 2020Medium confidence
US 7,338,652Methods for positron emission imaging with radiolabeled halogenated xanthenes diagnostic agents
Formerly held
Lapsed on the fee record
Ended Mar 4, 2020 · USPTO record
Lapsed on the fee recordEnded Mar 4, 2020USPTO record
US 6,986,740Ultrasound contrast using halogenated xanthenes
Formerly held
Term ended
Term ended Aug 3, 2019 · USPTO record
Term endedTerm ended Aug 3, 2019USPTO record
US 6,991,776Intracorporeal medicaments for high energy phototherapeutic treatment of disease
Formerly held
Term ended
Term ended Feb 24, 2019 · USPTO record
Term endedTerm ended Feb 24, 2019USPTO record
US 6,331,286Methods for high energy phototherapeutics
Formerly held
Term ended
Term ended Dec 21, 2018 · USPTO record
Term endedTerm ended Dec 21, 2018USPTO record
10 of 25 patents shown.
Pro members see all 25.
Pro members: see all 25 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited